Avego is a healthcare-focused venture capital firm investing across biotechnology, therapeutics, medical products and services. Through Avego BioScience Capital it targets mid-to-late-stage venture financings for biotech companies, alongside growth investments in commercial-stage healthcare businesses and public healthcare equities through related strategies. Based in Alpharetta, Georgia and New York, the firm invests in the United States and is relevant for founders in later-stage life sciences, pharmaceuticals, HealthTech and medical device sectors.